Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biomerica Inc BMRA

Healthcare Medical Devices
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two... see more

Recent & Breaking News (NDAQ:BMRA)

Dubai Government Grants Insurance Reimbursement for Biomerica's EZ Detect(TM) Colorectal Disease Screening Test

GlobeNewswire September 26, 2023

Diagnostics Industry Leader Jack Kenny Joins Biomerica's Board of Directors

GlobeNewswire August 28, 2023

Biomerica Reports Fiscal 2023 Year End Results

GlobeNewswire August 25, 2023

CVS Health to Begin Nationwide In-Store Sales of Biomerica's EZ Detect(TM) Colorectal Disease Screening Test

GlobeNewswire August 3, 2023

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients

GlobeNewswire June 21, 2023

inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology

GlobeNewswire May 18, 2023

Biomerica's inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

GlobeNewswire April 17, 2023

Biomerica Reports Q3 Fiscal 2023 Results

GlobeNewswire April 14, 2023

Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed

GlobeNewswire March 8, 2023

Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock

GlobeNewswire March 7, 2023

Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock

GlobeNewswire March 3, 2023

Biomerica Announces Proposed Underwritten Public Offering of Common Stock

GlobeNewswire March 2, 2023

Barnwell Industries, Inc. Reaches Cooperation and Support Agreement With its Largest Stockholders

GlobeNewswire January 23, 2023

Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

GlobeNewswire January 13, 2023

Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company's Scientific Advisory Board

GlobeNewswire January 10, 2023

Biomerica Receives KFDA and Ministry of Health Approval for Colorectal Screening and Breast Screening Tests in Saudi Arabia and UAE

GlobeNewswire December 8, 2022

Biomerica InFoods® IBS Data Presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting

GlobeNewswire November 2, 2022

Walmart to Expand Sales of Biomerica's Aware® Breast Self Exam; Product will now be available in over 2400 Walmart stores

GlobeNewswire October 14, 2022

Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022

GlobeNewswire October 13, 2022

Biomerica's Aware® Breast Self Exam and EZ Detect(TM) Colon Disease Test Now Available on Amazon and Fulfilled by Amazon

GlobeNewswire September 29, 2022